bomedemstat
Bomedemstat is a drug used to treat Extensive Stage Lung Small Cell Carcinoma, Primary Myelofibrosis, and Thrombocythemia, Essential. Bomedemstat is being actively studied in 2 studies; no studies for this drug have been completed so far.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
Imago BioSciences,Inc. | Fred Hutch/University of Washington Cancer Consortium | |
University of Washington | Queen Mary Hospital | |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
Recruiting
- Thrombocythemia, Essential
- Primary Myelofibrosis
- Bomedemstat
- Hong Kong, Hong KongQueen Mary Hospital
2022-01-24
Jan 24, 2022U
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- Limited Stage Lung Small Cell Carcinoma
- Bomedemstat
- Atezolizumab
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-03-30
Mar 30, 2022